Generic Name and Formulations:
Clobetasol propionate 0.05%; emulsion aerosol foam.
- Rimegepant Shows Efficacy and Safety in Treating Acute Migraine
- OnabotulinumtoxinA May Be Effective for Chronic Migraine With Medication Overuse
- Low-Dose Sumatriptan Injection Effective as Acute Migraine Treatment
- Antirheumatic Indications for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Arthritis Treatments: NSAIDs
- Neuropathic Pain Medications
Indications for OLUX-E:
≥12yrs: apply thin layer to affected area(s) twice daily (AM & PM); max 50g/week or 21 capfuls/week and 2 consecutive week's treatment per course. Discontinue when control is achieved. Wash hands after application. Do not occlude.
<12yrs: not recommended.
Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axillae, groin, or other intertriginous areas. Do not use for diaper dermatitis or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Product is flammable. Pregnancy. Nursing mothers.
Burning, stinging, pruritus, erythema, skin atrophy, folliculitis, dermal cracking and fissuring, telangiectasia, striae; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Emergency Physicians Offer Recommendations for Identifying and Managing Opioid Use Disorder
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness